ScholarIQanswers from OpenAlex

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future

PaperCitations, authors & open-access status

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future have?

ScholarIQcitation count

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future has 61 citations in the OpenAlex counts ScholarIQ stores.

When was Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future published?

ScholarIQyear

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future has 2022 year in the ScholarIQ index.

What is the open-access status of Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future?

ScholarIQoa status

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future has gold oa status in the ScholarIQ index.

What is the DOI of Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future?

ScholarIQdoi

The DOI for Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future is on the source record.

What is the PMID of Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future?

ScholarIQpmid

The PMID for Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future is on the source record.

What is the OpenAlex record for Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future?

ScholarIQopenalex

The OpenAlex for Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial